Breast Cancer in Men in the US: A population-based study of diagnosis, treatment and survival
Identifieur interne : 005A03 ( Main/Exploration ); précédent : 005A02; suivant : 005A04Breast Cancer in Men in the US: A population-based study of diagnosis, treatment and survival
Auteurs : Linda C. Harlan [États-Unis] ; Jo Anne Zujewski [États-Unis] ; Marc T. Goodman [États-Unis] ; Jennifer L. Stevens [États-Unis]Source :
- Cancer [ 0008-543X ] ; 2010.
Abstract
Breast cancer in men is rare, so clinical trials are not practical. Recommendations suggest that men diagnosed with breast cancer be treated using guidelines for postmenopausal women, but there are no population-based studies to evaluate patterns of care.
To examine characteristics, treatment and survival in men newly diagnosed with breast cancer in 2003and 2004, 512 men were identified from the Surveillance, Epidemiology and End-Results program. Data were re-abstracted and therapy verified through the patients’ treating physicians.
The majority (79%) of men were diagnosed through discovery of a breast lump or other signs/symptoms. In men with invasive disease 86% were treated with mastectomy, 37% received chemotherapy, and 58% received hormonal therapy. In multivariate analysis, tumor size (p=0.01) and positive nodes (p <0.0001) were positively associated with the use of chemotherapy; age group (p <0.0001) and not currently married (p=0.01) were negatively associated. In men with invasive ER positive/borderline tumors, the use of tamoxifen or aromatase inhibitors was associated with age group (p=0.05). Among men with invasive disease, cancer mortality was associated with tumor size (p<0.0001). Among men with ER positive/borderline disease increased cancer mortality was associated with tumor size (p<0.0001), not currently married (p=0.04) and decreased mortality with tamoxifen (p=0.04).
Tumor characteristics and marital status were the primary predictors of therapy and cancer mortality. Although AIs are not currently recommended they are commonly prescribed. However, they did not result in a decrease in cancer mortality. Research must examine the efficacy of AI’s with and without GnRH analogues.
Url:
DOI: 10.1002/cncr.25153
PubMed: 20564105
PubMed Central: 2910812
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 002777
- to stream Pmc, to step Curation: 002776
- to stream Pmc, to step Checkpoint: 003485
- to stream Ncbi, to step Merge: 003C00
- to stream Ncbi, to step Curation: 003C00
- to stream Ncbi, to step Checkpoint: 003C00
- to stream Main, to step Merge: 005A56
- to stream Main, to step Curation: 005A03
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Breast Cancer in Men in the US: A population-based study of diagnosis, treatment and survival</title>
<author><name sortKey="Harlan, Linda C" sort="Harlan, Linda C" uniqKey="Harlan L" first="Linda C." last="Harlan">Linda C. Harlan</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Applied Research Program, NCI, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Applied Research Program, NCI, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Zujewski, Jo Anne" sort="Zujewski, Jo Anne" uniqKey="Zujewski J" first="Jo Anne" last="Zujewski">Jo Anne Zujewski</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Clinical Trials Evaluation Program, NCI, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Clinical Trials Evaluation Program, NCI, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Goodman, Marc T" sort="Goodman, Marc T" uniqKey="Goodman M" first="Marc T." last="Goodman">Marc T. Goodman</name>
<affiliation wicri:level="2"><nlm:aff id="A3">Cancer Research Center, University of Hawai’i, Honolulu, HI</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Hawaï</region>
</placeName>
<wicri:cityArea>Cancer Research Center, University of Hawai’i, Honolulu</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Stevens, Jennifer L" sort="Stevens, Jennifer L" uniqKey="Stevens J" first="Jennifer L." last="Stevens">Jennifer L. Stevens</name>
<affiliation wicri:level="2"><nlm:aff id="A4">Information Management Services, Silver Spring, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Information Management Services, Silver Spring</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">20564105</idno>
<idno type="pmc">2910812</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910812</idno>
<idno type="RBID">PMC:2910812</idno>
<idno type="doi">10.1002/cncr.25153</idno>
<date when="2010">2010</date>
<idno type="wicri:Area/Pmc/Corpus">002777</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002777</idno>
<idno type="wicri:Area/Pmc/Curation">002776</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002776</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003485</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003485</idno>
<idno type="wicri:Area/Ncbi/Merge">003C00</idno>
<idno type="wicri:Area/Ncbi/Curation">003C00</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003C00</idno>
<idno type="wicri:doubleKey">0008-543X:2010:Harlan L:breast:cancer:in</idno>
<idno type="wicri:Area/Main/Merge">005A56</idno>
<idno type="wicri:Area/Main/Curation">005A03</idno>
<idno type="wicri:Area/Main/Exploration">005A03</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Breast Cancer in Men in the US: A population-based study of diagnosis, treatment and survival</title>
<author><name sortKey="Harlan, Linda C" sort="Harlan, Linda C" uniqKey="Harlan L" first="Linda C." last="Harlan">Linda C. Harlan</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Applied Research Program, NCI, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Applied Research Program, NCI, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Zujewski, Jo Anne" sort="Zujewski, Jo Anne" uniqKey="Zujewski J" first="Jo Anne" last="Zujewski">Jo Anne Zujewski</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Clinical Trials Evaluation Program, NCI, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Clinical Trials Evaluation Program, NCI, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Goodman, Marc T" sort="Goodman, Marc T" uniqKey="Goodman M" first="Marc T." last="Goodman">Marc T. Goodman</name>
<affiliation wicri:level="2"><nlm:aff id="A3">Cancer Research Center, University of Hawai’i, Honolulu, HI</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Hawaï</region>
</placeName>
<wicri:cityArea>Cancer Research Center, University of Hawai’i, Honolulu</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Stevens, Jennifer L" sort="Stevens, Jennifer L" uniqKey="Stevens J" first="Jennifer L." last="Stevens">Jennifer L. Stevens</name>
<affiliation wicri:level="2"><nlm:aff id="A4">Information Management Services, Silver Spring, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Information Management Services, Silver Spring</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Cancer</title>
<idno type="ISSN">0008-543X</idno>
<idno type="eISSN">1097-0142</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title>
<p id="P1">Breast cancer in men is rare, so clinical trials are not practical. Recommendations suggest that men diagnosed with breast cancer be treated using guidelines for postmenopausal women, but there are no population-based studies to evaluate patterns of care.</p>
</sec>
<sec sec-type="methods" id="S2"><title>Methods</title>
<p id="P2">To examine characteristics, treatment and survival in men newly diagnosed with breast cancer in 2003and 2004, 512 men were identified from the Surveillance, Epidemiology and End-Results program. Data were re-abstracted and therapy verified through the patients’ treating physicians.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P3">The majority (79%) of men were diagnosed through discovery of a breast lump or other signs/symptoms. In men with invasive disease 86% were treated with mastectomy, 37% received chemotherapy, and 58% received hormonal therapy. In multivariate analysis, tumor size (p=0.01) and positive nodes (p <0.0001) were positively associated with the use of chemotherapy; age group (p <0.0001) and not currently married (p=0.01) were negatively associated. In men with invasive ER positive/borderline tumors, the use of tamoxifen or aromatase inhibitors was associated with age group (p=0.05). Among men with invasive disease, cancer mortality was associated with tumor size (p<0.0001). Among men with ER positive/borderline disease increased cancer mortality was associated with tumor size (p<0.0001), not currently married (p=0.04) and decreased mortality with tamoxifen (p=0.04).</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P4">Tumor characteristics and marital status were the primary predictors of therapy and cancer mortality. Although AIs are not currently recommended they are commonly prescribed. However, they did not result in a decrease in cancer mortality. Research must examine the efficacy of AI’s with and without GnRH analogues.</p>
</sec>
</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Hawaï</li>
<li>Maryland</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Harlan, Linda C" sort="Harlan, Linda C" uniqKey="Harlan L" first="Linda C." last="Harlan">Linda C. Harlan</name>
</region>
<name sortKey="Goodman, Marc T" sort="Goodman, Marc T" uniqKey="Goodman M" first="Marc T." last="Goodman">Marc T. Goodman</name>
<name sortKey="Stevens, Jennifer L" sort="Stevens, Jennifer L" uniqKey="Stevens J" first="Jennifer L." last="Stevens">Jennifer L. Stevens</name>
<name sortKey="Zujewski, Jo Anne" sort="Zujewski, Jo Anne" uniqKey="Zujewski J" first="Jo Anne" last="Zujewski">Jo Anne Zujewski</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005A03 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005A03 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= PMC:2910812 |texte= Breast Cancer in Men in the US: A population-based study of diagnosis, treatment and survival }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20564105" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |